Az emlorák korszeru patológiai diagnosztikája

Translated title of the contribution: Modern pathologic diagnostics of breast cancer

Szoke János, N. Udvarhelyi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The diagnosis of breast cancer is morphologically based. Pathologic parameters, such as tumor size, lymph node status, and histological grade are well accepted to guide treatment decisions in clinical practice. Estrogen receptor, progesterone receptor and HER2 status are also routinely assessed in today's pathology laboratories to provide further information on predictive and prognostic factors affecting patients' care. Newer molecular techniques, including gene-expression profiling have been widely used to study breast cancer and several molecular prognostic tests already available for clinical use stemmed from these scientific efforts. Authors review prognostically important aspects of the diagnostic pathology and the molecular classification of invasive breast cancer.

Original languageHungarian
Pages (from-to)22-30
Number of pages9
JournalOrvosi Hetilap
Volume153
Issue number1
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Breast Neoplasms
Molecular Pathology
Gene Expression Profiling
Progesterone Receptors
Estrogen Receptors
Patient Care
Lymph Nodes
Pathology
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az emlorák korszeru patológiai diagnosztikája. / János, Szoke; Udvarhelyi, N.

In: Orvosi Hetilap, Vol. 153, No. 1, 01.01.2012, p. 22-30.

Research output: Contribution to journalArticle

János, Szoke ; Udvarhelyi, N. / Az emlorák korszeru patológiai diagnosztikája. In: Orvosi Hetilap. 2012 ; Vol. 153, No. 1. pp. 22-30.
@article{1e31f8837c03450aa667531828a031f1,
title = "Az emlor{\'a}k korszeru patol{\'o}giai diagnosztik{\'a}ja",
abstract = "The diagnosis of breast cancer is morphologically based. Pathologic parameters, such as tumor size, lymph node status, and histological grade are well accepted to guide treatment decisions in clinical practice. Estrogen receptor, progesterone receptor and HER2 status are also routinely assessed in today's pathology laboratories to provide further information on predictive and prognostic factors affecting patients' care. Newer molecular techniques, including gene-expression profiling have been widely used to study breast cancer and several molecular prognostic tests already available for clinical use stemmed from these scientific efforts. Authors review prognostically important aspects of the diagnostic pathology and the molecular classification of invasive breast cancer.",
keywords = "breast cancer, molecular classifi cation, pathology, predictive markers, prognosis",
author = "Szoke J{\'a}nos and N. Udvarhelyi",
year = "2012",
month = "1",
day = "1",
doi = "10.1556/OH.2012.29251",
language = "Hungarian",
volume = "153",
pages = "22--30",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Az emlorák korszeru patológiai diagnosztikája

AU - János, Szoke

AU - Udvarhelyi, N.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The diagnosis of breast cancer is morphologically based. Pathologic parameters, such as tumor size, lymph node status, and histological grade are well accepted to guide treatment decisions in clinical practice. Estrogen receptor, progesterone receptor and HER2 status are also routinely assessed in today's pathology laboratories to provide further information on predictive and prognostic factors affecting patients' care. Newer molecular techniques, including gene-expression profiling have been widely used to study breast cancer and several molecular prognostic tests already available for clinical use stemmed from these scientific efforts. Authors review prognostically important aspects of the diagnostic pathology and the molecular classification of invasive breast cancer.

AB - The diagnosis of breast cancer is morphologically based. Pathologic parameters, such as tumor size, lymph node status, and histological grade are well accepted to guide treatment decisions in clinical practice. Estrogen receptor, progesterone receptor and HER2 status are also routinely assessed in today's pathology laboratories to provide further information on predictive and prognostic factors affecting patients' care. Newer molecular techniques, including gene-expression profiling have been widely used to study breast cancer and several molecular prognostic tests already available for clinical use stemmed from these scientific efforts. Authors review prognostically important aspects of the diagnostic pathology and the molecular classification of invasive breast cancer.

KW - breast cancer

KW - molecular classifi cation

KW - pathology

KW - predictive markers

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=84855262931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855262931&partnerID=8YFLogxK

U2 - 10.1556/OH.2012.29251

DO - 10.1556/OH.2012.29251

M3 - Article

VL - 153

SP - 22

EP - 30

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 1

ER -